COVID-19 - VACCELERATE Webinar - Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants after fourth Vaccination or Tixagevimab and Cilgavimab Administration in Cancer Patients
| Event title | Event dates | Event venue | Website of the event | Main speciality | Name of the CME provider | Amount of ECMEC® credits |
|---|---|---|---|---|---|---|
| COVID-19 - VACCELERATE Webinar - Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants after fourth Vaccination or Tixagevimab and Cilgavimab Administration in Cancer Patients | 27/09/2022 - 27/09/2022 | Germany, Cologne | Website | Infectious Diseases | University Hospital Cologne | 0.0 European CME credits (ECMEC®) |
